Recently, a mechanism of tumor invasion has been identified where MDSCs alter the structureof MHC class I expressed on the tumor cell surface, preventing the binding of processedpeptide that would otherwise activate antigen-specific CD8+ T cells (Luet al., 2011). The gene discussed is CD8A; the disease is neoplasm.